1Bruch C, Schmermund A, Dagres N, et al. Changes in QRS voltage in cardiac tamponade and pericardial effusion: Reversibility after pericardiocentesis and after anti-inflammatory drug treatment.J Am Cardiol, 2002,38(1) : 219 - 226.
3Karam N, Patel P, de Filippi C. Diagnosis and management of chronic pericardial effusions. Am J Med Sci,2001,322(2) : 79- 87.
4Scarpinato L. Pericardial effusion and cardiac tamponade diagnostic methods. Chest, 1996,110(2) :308-310.
5Salem K, Mulji A, Lonn E. Echocardiographically guided pericardiocentesis: The gold standard for the management of pericardial effusion and cardiac tamponade.Can J Cardiol, 1999, 15(11) : 1251 - 1255.
6Chen HH, Burnett JC Jr. C-type natriuretic peptide: the endothelial component of the natriuretic peptide system. J Cardiovasc Pharmacol 1998;32 Suppl 3:s22
7Nir A, Zhang DF, Fixler R, Burnett JC JR, et al. C-type natriuretic peptide has a negative inotropic effect on cardiac myocytes. Eur J Pharmacol 2001 Feb 2; 412(3):195
8杨刚,主编.内分泌生理与病理生理学.第2版.天津:天津科学技术出版社.2000;655
9Seungbum K, Yasuyoshi O, Hiromichi S, et al. Endogenous calcitonin gene-related peptide modulates tachycardiac but not bradycardic baroreflex in rats. American Physiological Society 1998 May; 274(5):H1489
